治疗性连接剂通过损害其移动性来对抗雌激素受体功能
Jane Guan1, Wei Zhou1, Marc Hafner2
1Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.
Cell
|July 30, 2019
概括
优化雌激素受体 (ER) 降解并不能保证乳腺癌的完全对抗作用. 减缓ER核移动, 而不是消除, 抑制ER活动, 提供新的治疗策略.
科学领域:
- 癌症学
- 分子生物学
- 内分泌学
背景情况:
- 雌激素受体阳性 (ER+) 乳腺癌尽管对内分泌疗法有抗性,但通常仍然依赖于ER.
- 富尔韦斯特兰是一种完全的ER抗剂,被认为通过ER降解起作用,但其物理化学性质较差.
- 开发具有改进性质的ER降解剂是关键的治疗目标.
研究的目的:
- 调查ER降解和ER对抗之间的关系.
- 探索ER抗剂抑制ER活动的机制.
- 评估针对转录因子移动性的治疗潜力.
主要方法:
- 评估ER降解剂在乳腺癌细胞中的转录活性和抗增殖作用.
- 分析对手对ER核动力和营业额的影响.
- 调查ER固定和转录抑制之间的联系.
主要成果:
- ER降解剂表现出一系列的转录活动和抗增殖潜力,不仅仅取决于降解.
- 通过显著降低ER核内移动性,富尔韦斯特兰特类抗剂抑制ER活性.
- 这会增加ER的流量,从而导致对抗.
结论:
- 优化ER降解并不等同于完全的ER对抗性.
- 扰乱转录因子的移动性,特别是ER核的移动性,是ER对抗的一个可行的机制.
- 针对转录因子的移动性为依赖转录因子的癌症提供了一种新的治疗策略.
更多相关视频
14:13Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
Published on: January 1, 2018
13.7K
07:13Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
944
相关概念视频
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Agonism and Antagonism: Quantification
1.0K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.0K
Internal Receptors
74.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.8K
Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Combined Effects of Drugs: Antagonism
11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
